Foto del docente

Arrigo Francesco Giuseppe Cicero

Associate Professor

Department of Medical and Surgical Sciences

Academic discipline: MEDS-08/C Food and Dietetic Sciences

Head of Scuola di Specializzazione Scienza dell'Alimentazione (68/2015)

Publications

Pierdomenico M, Cicero AFG, Veronesi M, Fogacci F, Riccioni C, Benassi B, Effect of Citrus bergamia extract on lipid profile: A combined in vitro and human study, «PHYTOTHERAPY RESEARCH», 2023, 37, pp. 4185 - 4195 [Scientific article]Open Access

Fogacci F, Degli Esposti D, Di Micoli A, Fiorini G, Veronesi M, Borghi C, Cicero AFG., Effect of dietary supplementation with Diuripres® on blood pressure, vascular health, and metabolic parameters in individuals with high-normal blood pressure or stage I hypertension: The CONDOR randomized clinical study, «PHYTOTHERAPY RESEARCH», 2023, 37, pp. 4851 - 4861 [Scientific article]Open Access

Ehlrich A, Ioannidis K. Nasar M., Alkian IA, Daskal Y, Atari N, Kliker L, Rainy N, Hofree M, Tikva SS, Houri I, Cicero AF, Pavanello C, Sirtori CI, CohenJB, Chirinos JA, Deutsch L, Cohen M, Gottlieb A, Bar-Chaim A, Shibolet O, Mandelboim M, Maayan S, Nahmias Y., Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study, «ELIFE», 2023, 12, Article number: e79946 , pp. 1 - 36 [Scientific article]Open Access

Cicero, A. F. G.; Fogacci, F.; Giovannini, M.; Grandi, E.; D'Addato, S.; Borghi, C., Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting, «BIOMEDICINES», 2023, 11, Article number: 3289 , pp. 1 - 12 [Scientific article]Open Access

Fogacci, F; Giovannini, M; Di Micoli, V; Grandi, E; Veronesi, M; Borghi, C; Cicero, ARRIGO FRANCESCO GIUSEPPE, Evaluation of the effect of a dietary supplementation with a red yeast rice and fish oil-containing nutraceutical on lipid pattern, high sensitivity C-reactive protein, and endothelial function in moderately hypercholesterolaemic subjects: a double-blind, placebo-controlled, randomized clinical trial., «ARCHIVES OF MEDICAL SCIENCES. ATHEROSCLEROTIC DISEASES», 2023, 8, pp. 182 - 189 [Scientific article]

Palatini P, Virdis A, Masi S, Mengozzi A, Casiglia E, Tikhonoff V, Cicero AFG, Ungar A, Parati G, Rivasi G, Salvetti M, Barbagallo CM, Bombelli M, Dell'Oro R, Bruno B, Lippa L, D'Elia L, Masulli M, Verdecchia P, Reboldi G, Angeli F, Mallamaci F, Cirillo M, Rattazzi M, Cirillo P, Gesualdo L, Mazza A, Giannattasio C, Maloberti A, Volpe M, Tocci G, Iaccarino G, Nazzaro P, Galletti F, Ferri C, Desideri G, Viazzi F, Pontremoli R, Muiesan ML, Grassi G, Borghi C; from the Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA)., Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol level., «NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES», 2023, 33, pp. 323 - 330 [Scientific article]

Fogacci F, Borghi C, Davinelli S, Scapagnini G, Cicero AFG., Impact of anti-oestrogen therapy on lipoprotein(a) in postmenopausal women: a systematic review and meta-analysis of double-blind placebo-controlled clinical studies., «ENDOCRINE», 2023, 80, pp. 292 - 302 [Scientific article]

Poli A, Catapano AL, Corsini A, Manzato E, Werba JP, Catena G, Cetin I, Cicero AFG, Cignarella A, Colivicchi F, Consoli A, Landi F, Lucarelli M, Manfellotto D, Marrocco W, Parretti D, Perrone Filardi P, Pirillo A, Sesti G, Volpe M, Marangoni F, LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals, «NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES», 2023, 33, pp. 245 - 257 [Scientific article]Open Access

Surma, S; Sahebkar, A; Banach, M; Endorsed By The International Lipid Expert Panel, (ILEP); Cicero, Arrigo Francesco Giuseppe, Low carbohydrate/ketogenic diet in the optimization of lipoprotein(a) levels: do we have sufficient evidence for any recommendation?, «EUROPEAN HEART JOURNAL», 2023, 44, pp. 4904 - 4906 [Scientific article]

Fogacci F, Giovannini M, Imbalzano E, Grandi E, Rizzoli E, D'Addato S, Cicero AFG, Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebocontrolled, double-blind clinical trial, «ARCHIVES OF MEDICAL SCIENCE», 2023, 19, pp. 1228 - 1235 [Scientific article]Open Access

Risoli S, Nali C, Sarrocco S, Cicero AFG, Colletti A, Bosco F, Venturella G, Gadaleta A, Gargano ML, Marcotuli I., Mushroom-Based Supplements in Italy: Let’s Open Pandora’s Box, «NUTRIENTS», 2023, 15, Article number: 776 , pp. 1 - 14 [Scientific article]Open Access

Orlando L, Bagnato G, Ioppolo C, Franzè MS, Perticone M, Versace AG, Sciacqua A, Russo V, Cicero AFG, De Gaetano A, Dattilo G, Fogacci F, Tringali MC, Di Micco P, Squadrito G, Imbalzano E., Natural Course of COVID-19 and Independent Predictors of Mortality., «BIOMEDICINES», 2023, 11, Article number: 939 , pp. 1 - 9 [Scientific article]Open Access

Rizzo M, Colletti A, Penson PE, Katsiki N, Mikhailidis DP, Toth PP, Gouni-Berthold I, Mancini J, Marais D, Moriarty P, Ruscica M, Sahebkar A, Vinereanu D, Cicero AFG, Banach M; International Lipid Expert Panel (ILEP), Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP), «PHARMACOLOGICAL RESEARCH», 2023, 189, Article number: 106679 , pp. 1 - 21 [Scientific article]Open Access

Medoro, A.; Davinelli, S.; Colletti, A.; Micoli, V. D.; Grandi, E.; Fogacci, F.; Scapagnini, G.; Cicero, A. F. G., Nutraceuticals as Modulators of Immune Function: A Review of Potential Therapeutic Effects, «PREVENTIVE NUTRITION AND FOOD SCIENCE», 2023, 28, pp. 89 - 107 [Scientific article]Open Access

Borghi, Claudio; Cicero, Arrigo Fg; Agnoletti, Davide; Fiorini, Giulia, Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences?, «EUROPEAN JOURNAL OF INTERNAL MEDICINE», 2023, 110, pp. 10 - 15 [Scientific article]Open Access

Latest news

At the moment no news are available.